Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating expenses:
Research and development	$ 15,533	$ 16,039
General and administrative	20,624	9,784
Total operating expenses	36,157	25,823
Loss from operations	(36,157)	(25,823)
Other income	1,418	315
Interest income	1,203	49
Interest expense	(3,302)	(2,575)
Net loss	$ (36,838)	$ (28,034)
Net loss per share, basic	$ (1.30)	$ (1.02)
Net loss per share, diluted	$ (1.30)	$ (1.02)
Weighted --average common shares outstanding, basic	28,358,502	27,351,730
Weighted--average common shares outstanding, diluted	28,358,502	27,351,730
Other comprehensive loss:
Unrealized (loss) gain on short-term investments	$ 33	$ (2)
Comprehensive loss	$ (36,805)	$ (28,036)